From Archetypes to Access: A Two-Axis Governance Framework and Decision-Support Tool for Rare Specimen Biobanking
Authors:
- 21 September 2026
- journal article
- research article
- Published by SAGE Publications in Biopreservation and Biobanking
Abstract
Introduction: Biobanks fulfill their scientific and ethical mandates when collected specimens are used effectively. Access policies govern researcher eligibility, allocation, oversight, and intellectual property (IP) considerations. Despite their importance, access policies vary substantially and lack a unifying practical framework. Objectives: We sought to identify commonalities and areas of under-specification across access policies in surgically oriented, pediatric, and/or national biobanks to describe real-world practices and develop a typology of rare biospecimen governance. Methods: We conducted a targeted scoping review of access policies from 32 biobanks identified from the Biobank Resource Centre Biobank Locator, with 19 providing sufficient governance information (59% response). Responses were coded using 10 domains researcher eligibility, oversight, allocation rules, data/sample coupling, industry access, fees, reporting, authorship, unused sample handling, and IP. Descriptive statistics and comparative analysis were used to identify patterned co-variation. A large language model (ChatGPT and OpenAI) was used to organize coded attributes and generate potential governance typologies, which were refined and verified by the authors. Results: Governance attributes clustered along two conceptually distinct dimensions Access Orientation (facilitative vs. stewardship-oriented) and Allocation Logic (procedurally neutral vs. strategically prioritized). Their interaction produced four corresponding governance archetypes: Academic Commons, Rare Specimen Stewardship, Investigator-Led Facilitation, and Protected National Strategic Asset. Unused sample handling and IP were the most frequently under-specified domains. No novel structural configurations emerged after 13 cases. Conclusion: Access policy variations reflect coherent governance orientations that reveal differing institutional priorities and conceptions of the biobank’s role in research facilitation and stewardship. By articulating two analytic axes and four archetypes, we provide a practical framework for interpreting policy differences across biobanks and identifying areas of under-specification. New and evolving biobanks can use this typology to align policies with their mission, scarcity constraints, and ethical obligations, supporting transparent decision-making and responsible and effective use of research specimens.Keywords
Funding Information
- Women & Children’s Health Research Institute (Graduate Studentship #4110 (E.P.L.))
- Women & Children’s Health Research Institute (Innovation Grant (T.P.))
- Weston Family Foundation (POP25-12021 (T.P.))
This publication has 21 references indexed in Scilit:
- Advancing Professionalization of Biobank Business Operations: Performance and UtilizationBiopreservation and Biobanking, 2019
- Commentary on Improving Biospecimen Utilization by Classic Biobanks: Identifying Past and Minimizing Future MistakesBiopreservation and Biobanking, 2019
- Current practices for access, compensation, and prioritization in biobanks. Results from an interview studyEuropean Journal of Human Genetics, 2018
- Population Biobanks’ Governance: A Case Study of Knowledge Commons2017
- Access policies in biobank research: what criteria do they include and how publicly available are they? A cross-sectional studyEuropean Journal of Human Genetics, 2016
- Governing the Commons2015
- Access to Biobanks: Harmonization Across Biobank InitiativesBiopreservation and Biobanking, 2014
- Biorepository Regulatory Frameworks: Building Parallel Resources That Both Promote Scientific Investigation and Protect Human SubjectsJournal of Proteome Research, 2014
- Biobank governance: heterogeneous modes of ordering and democratizationJournal of Community Genetics, 2011
- Allocation of Scarce Resources2007